Safety considerations are covered in GLP-1 safety guides
Can fiber replace semaglutide (injectable)
Theyre typically self-injected with a small needle into the fatty layer just under the skin
NAION is a very rare eye disease, and it is not an adverse drug reaction for the marketed formulations of semaglutide (Ozempic, Rybelsus and Wegovy) as per the approved labels in the U.S." "Novo Nordisk, on its part, has conducted an analysis across randomized controlled clinical trials with GLP-1 receptor agonists, including a blinded ophthalmologist evaluation to confirm NAION diagnoses
With the knowledge that UF is hormone-dependent, pharmacological agents that target the hormonal pathways, such as gonadotropin-releasing hormone (GnRH) agonist, selective progesterone receptor modulator (SPRM), and aromatase inhibitor, have been developed as a treatment choice for UF